Mankind Pharma (India) Today
| MANKIND Stock | 2,245 83.15 3.85% |
PerformanceVery Weak
| Odds Of DistressVery Small
|
Mankind Pharma is trading at 2244.85 as of the 21st of March 2025, a 3.85 percent increase since the beginning of the trading day. The stock's lowest day price was 2166.6. Mankind Pharma has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Mankind Pharma is entity of India. It is traded as Stock on NSE exchange. The company has 412.58 M outstanding shares. More on Mankind Pharma
Moving together with Mankind Stock
| 0.89 | LICI | Life InsuranceOf | PairCorr |
| 0.71 | PFC | Power FinanceLimited | PairCorr |
| 0.74 | SBIN | State Bank | PairCorr |
| 0.84 | RECLTD | REC Limited | PairCorr |
| 0.81 | IRFC | Indian Railway Finance | PairCorr |
Moving against Mankind Stock
| 0.71 | ASIANHOTNR | Asian Hotels Limited | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Mankind Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mankind Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mankind Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Sheetal Arora | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) | ||||
Mankind Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Mankind Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsMankind Pharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mankind Pharma's financial leverage. It provides some insight into what part of Mankind Pharma's total assets is financed by creditors.
| |||||
Mankind Pharma (MANKIND) is traded on National Stock Exchange of India in India and employs 19,540 people. Mankind Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 926.18 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mankind Pharma's market, we take the total number of its shares issued and multiply it by Mankind Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mankind Pharma operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 412.58 M outstanding shares.
Mankind Pharma generates positive cash flow from operations, but has no cash available
Check Mankind Pharma Probability Of Bankruptcy
Ownership AllocationMankind Pharma maintains a total of 412.58 Million outstanding shares. Mankind Pharma secures majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 72.7 % of Mankind Pharma outstanding shares that are owned by insiders conveys that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Mankind Ownership Details
Mankind Pharma Risk Profiles
Although Mankind Pharma's alpha and beta are two of the key measurements used to evaluate Mankind Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.93 | |||
| Standard Deviation | 2.51 | |||
| Variance | 6.31 | |||
| Risk Adjusted Performance | (0.09) |
Mankind Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Mankind Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Other Information on Investing in Mankind Stock
Mankind Pharma financial ratios help investors to determine whether Mankind Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mankind with respect to the benefits of owning Mankind Pharma security.